Nosustrophine: An Epinutraceutical Bioproduct with Effects on DNA Methylation, Histone Acetylation and Sirtuin Expression in Alzheimer’s Disease

Alzheimer’s disease (AD), the most common cause of dementia, causes irreversible memory loss and cognitive deficits. Current AD drugs do not significantly improve cognitive function or cure the disease. Novel bioproducts are promising options for treating a variety of diseases, including neurodegene...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Iglesias, Olaia, Naidoo, Vinogran, Carrera, Iván, Corzo, Lola, Cacabelos, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698419/
https://www.ncbi.nlm.nih.gov/pubmed/36432638
http://dx.doi.org/10.3390/pharmaceutics14112447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698419/
https://www.ncbi.nlm.nih.gov/pubmed/36432638
http://dx.doi.org/10.3390/pharmaceutics14112447

Ejemplares similares